Highlights & Benefits
Cognivue was designed to measure a patient's early clinical risk score objectively, quantitatively and reliably. It allows clinicians the opportunity to preserve a patient's cognitive health by establishing a baseline cognitive score that can be monitored over time.
Early clinical risk score allows for early identification, risk stratification and intervention to improve patient care.
10 Tests in 10 Minutes
Ten, one-minute, separately scored sub-tests measure tracking movement, vision, perception and memory of letters, words, shapes, and motion.
Cognivue clinical risk score is easy to understand and communicate. It is summarized in a one-page report.
Cognivue objectively measures and monitors cognitive function by testing 4 key cognitive domains.
How Cognivue Works
Unlike paper & pencil cognitive testing, Cognivue is based on neurophysiology and psychophysical research .
Seeing Cognivue in action makes it easy to learn about the technology and our 10-minute test of cognitive function.
Simple test results. Easy to understand. Easy to communicate.
Upon completion of the 10 minute test, Cognivue immediately creates a report with a clinical risk score of cognitive health. Using the patient's risk score, you will be able to determine the patient's risk stratification and proper course of action to improve patient care.Learn About our Report
It improved my ability to work with dementia patients and their CGs…I especially like the graphics.Dr. R. Mittereder, Unity Geriatrics
Victor-based company measures cognitive function with first FDA-cleared digital test ROCHESTER, N.Y., July 10, 2018—Victor-headquartered Cognivue, Inc., owned by Tom Golisano, is positioning itself for the rapid expansion of its Cognivue system….
Sign-up to schedule a Cognivue demo!Click Here